Q3 2019 Dare Bioscience Inc Earnings Call Transcript
Welcome to the conference call hosted by Daré Bioscience to review financial results for the quarter ending September 30, 2019, and to provide a general business update. This call is being recorded. My name is Sarah, and I will be your operator today.
With us are Sabrina Martucci Johnson, Daré's President and Chief Executive Officer; John Fair, Chief Business Development Officer; and Lisa Walters-Hoffert, Daré's Chief Financial Officer. Ms. Johnson, please proceed.
© -
Thank you, and welcome to our financial results and business update call for Daré Bioscience. It's a pleasure to have the opportunity to talk about our third quarter results and our company highlights and upcoming milestones for the remainder of 2019 and 2020.
Before I begin, I would like to remind you that today's discussion will include forward-looking statements within the meaning of the federal securities laws, which are made pursuant to the safe harbor
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |